すべての画像(1)
About This Item
実験式（ヒル表記法）:
C15H13NO2
CAS番号:
分子量:
239.27
Beilstein:
4188192
MDL番号:
UNSPSCコード:
12352005
PubChem Substance ID:
NACRES:
NA.22
おすすめの製品
アッセイ
≥99.0% (HPLC)
フォーム
solid
mp
201-204 °C
溶解性
dioxane: 15 mg/mL, clear, colorless
アプリケーション
peptide synthesis
SMILES記法
NC(=O)OCC1c2ccccc2-c3ccccc13
InChI
1S/C15H13NO2/c16-15(17)18-9-14-12-7-3-1-5-10(12)11-6-2-4-8-13(11)14/h1-8,14H,9H2,(H2,16,17)
InChI Key
ZZOKVYOCRSMTSS-UHFFFAOYSA-N
保管分類コード
13 - Non Combustible Solids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
個人用保護具 (PPE)
Eyeshields, Gloves, type N95 (US)
Choi Yi Li et al.
Chembiochem : a European journal of chemical biology, 20(1), 46-50 (2018-09-19)
Urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) are two serine proteases that contribute to initiating fibrinolysis by activating plasminogen. uPA is also an important tumour-associated protease due to its role in extracellular matrix remodelling. Overexpression of uPA has
Simon J de Veer et al.
The Biochemical journal, 469(2), 243-253 (2015-05-20)
Laskowski inhibitors regulate serine proteases by an intriguing mode of action that involves deceiving the protease into synthesizing a peptide bond. Studies exploring naturally occurring Laskowski inhibitors have uncovered several structural features that convey the inhibitor's resistance to hydrolysis and
アクティブなフィルタ
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）
